Patent 7975690 was granted and assigned to OptiNose on July, 2011 by the United States Patent and Trademark Office.
The present invention relates to a nasal delivery device for and a method of delivering a substance, in particular one of a liquid, as a suspension or solution, or a powder containing a medicament, especially systemic or topical pharmaceuticals, or a vaccine to the nasal airway of a subject.